ONCO.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$123M	+56.7%	$-0.47	$-0.53–$-0.41	—	1
2027	$231M	+87.8%	$-0.23	$-0.28–$-0.19	—	2
2028	$305M	+32.0%	$-0.04	$-0.05–$-0.03	—	2
2029	$689M	+125.8%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ONCO.STOncopeptides AB (publ)	$1.63	+0.31%	$393M	—
BICO.STBICO Group AB (publ)	$20.45	-0.24%	$1.4B	—
CANTA.STCantargia AB (publ)	$1.58	-0.69%	$445M	—
DMYD-B.STDiamyd Medical AB (publ)	$1.01	-0.20%	$154M	—
GENO.STGenovis AB	$20.30	+1.00%	$1.3B	—
IBT-B.STInfant Bacterial Therapeutics AB (publ)	$66.00	+1.54%	$859M

Source: Financial Modeling Prep · peers by sector/industry

Oncopeptides AB (publ)

Oncopeptides AB (publ) is a biotechnology firm dedicated to developing medical therapies for cancer, serving markets across the United States, Europe, and worldwide. Its foremost experimental compound, melflufen, is a distinct peptide-drug conjugate engineered to address multiple myeloma that has relapsed or become resistant to prior treatments in adult individuals. Founded in 2000, Oncopeptides AB (publ) conducts its main business from Stockholm, Sweden.

www.oncopeptides.com/sv

Employees: 69
IPO / List date: Feb 22, 2017
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ONCO.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ONCO.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ONCO.ST yet.